Snowball logo
logo
6039

Dali Pharmaceutical Co Ltd

603963 SHG
¥1.18¥0.00  (0%)
💡 Click on a row in the table to make it appear on the graph
📊 Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20192020202120222023TTM
Revenue
Total revenue
294.3213.6171.5132.387.2761.64
COGS
73.2257.0745.9457.7950.9756.97
Gross Profit
221.1156.5125.674.5636.34.671552
Operating Expenses & Income
Operating Income
10.39(1.631858)(13.23)(22.4)(24.13)(28.2)
Total Operating Expenses
283.9215.2184.7154.7111.489.85
R&D Expenses
2.2304662.8288831.4408630.9269890.8395241.063468
Selling General & Admin Expenses
191.7138120.678.7445.0130.16
Earnings from Continuing Operations
Interest Expense
(0.0196)-(0.247345)(1.078064)(1.708697)(1.081489)
Interest Income
0.2726350.2550620.2284660.2088520.1176820.138248
Income Tax Expense
3.6175390.5442480.2986970.703966--
Net Income
Net Income
13.513.231666(41.89)(17.7)(20.03)(24.38)
Supplemental
EBIT
6.172611(1.727684)(13.22)(22.4)--
EBITDA
33.4714.3(23.84)1.930256--
In millions of CNY, except % and values per 1 share